Akoya Biosciences Inc (AKYA)
2.62
-0.11
(-4.03%)
USD |
NASDAQ |
Nov 04, 16:00
2.62
0.00 (0.00%)
After-Hours: 20:00
Akoya Biosciences Shareholders Equity (Quarterly): 22.25M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 22.25M |
| March 31, 2024 | 32.72M |
| December 31, 2023 | 53.77M |
| September 30, 2023 | 61.97M |
| June 30, 2023 | 71.90M |
| March 31, 2023 | 42.12M |
| December 31, 2022 | 58.58M |
| September 30, 2022 | 75.09M |
| Date | Value |
|---|---|
| June 30, 2022 | 90.85M |
| March 31, 2022 | 106.55M |
| December 31, 2021 | 121.35M |
| September 30, 2021 | 137.39M |
| June 30, 2021 | 147.82M |
| March 31, 2021 | -60.00M |
| December 31, 2020 | -51.03M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-60.00M
Minimum
Mar 2021
147.82M
Maximum
Jun 2021
60.76M
Average
61.97M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| Bruker Corp | 1.789B |
| Azenta Inc | 1.990B |
| Harvard Bioscience Inc | 67.25M |
| Bionano Genomics Inc | 80.34M |
| Singular Genomics Systems Inc | 137.71M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 143.74M |
| Total Liabilities (Quarterly) | 121.50M |
| Debt to Equity Ratio | 3.402 |
| Current Ratio | 2.734 |
| Net Debt Paydown Yield | -2.11% |